Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes by unknown
INDEPENDENT REGULATION OF TUMOR NECROSIS
FACTOR AND LYMPHOTOXIN PRODUCTION BY HUMAN
PERIPHERAL BLOOD LYMPHOCYTES
BY MARIA CRISTINA CUTURI, MARIANNE MURPHY,
MARIA PATRICIA COSTA-GIOMI, ROBERTO WEINMANN,
BICE PERUSSIA, AND GIORGIO TRINCHIERI
From The Wistar Institute ofAnatomy and Biology, Philadelphia, Pennsylvania 19104
Tumor necrosis factor (TNF)' and lymphotoxin (LT) are two partially homol-
ogous factors originally described on the basis of their cytotoxic or cytostatic
effects on tumor cell lines (1-3). Purification studies and cloning of genes for
TNF and LT have allowed more detailed studies of the biology of these factors
(4-8). In addition to their cytotoxic activity, TNF and LT exert regulatory
effects on various cell types, e.g ., they act as growth factors and exert antiviral
activity on fibroblasts (9-11), activate endothelial cells (12), and regulate prolif-
eration, differentiation, and functions of myelomonocytic cells at all stages of
differentiation (13-18) .
LT is a product of activated lymphocytes, both B andT cells, whereas TNF
has been considered exclusively a product of monocytes/macrophages (3, 19) .
However, the possibility that at least some lymphocyte subsets can produceTNF
was suggested by our observation that supernatants from human peripheral
blood natural killer (NK) cells cocultured with NK-sensitive target cells or with
normal bone marrow cells contain a factor that inhibits colony formation and
that has antigenic and physicochemical characteristics ofTNF (14) . NK cells also
produce a cytotoxic factor (NKCF) active on NK-sensitive target cell lines (20) .
There is evidence to suggest that the cytotoxic activity ofNKCF canbe attributed
to more than one protein, because anti-TNF antibodies inhibit the activity of
NKCF when assayed on TNF-sensitive target cells such as the macrophage line
U937 (14, 21), but not on the TNF-resistant erythromyeloid line K562 (21, 22) .
Thus, the cytotoxic activity mediated by NK cells cannot be attributed solely to
TNF, with the possible exception of lysis of TNF-sensitive target cells (22) . The
possibility that lymphocytes are producers of TNF was also suggested by studies
showing that IL-2-dependent NK and T cell lines and a T cell tumor-derived
line, HUT-102, produce cytotoxins that are inhibited by anti-TNF antibodies
(23, 24). Aderka et al . (25) showed that mitogen-stimulated lymphocytes produce,
in addition to LT, a cytotoxic molecule with characteristics of TNF, although
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participation of monocyte/macrophages was not ruled out. Rubin et al . (26)
presented evidence that LT-resistant L cellsconstitutively produce TNF, showing
that TNF is not a specific product of monocyte/macrophages .
In this study, we show that human peripheral blood lymphocytes, carefully
depleted of contaminating monocytes, rapidly accumulate message for TNF and
produce high levels of TNF protein when stimulated with phorbol diester and
calcium ionophore, or with mitogen . The message for LT is also detected in
these cells, but the regulation of LT gene expression appears to be independent
of the TNF gene.
Materials and Methods
Cell lines.
￿
The human promyelocytic HL-60 cell line, the murine antibody-secreting
somatic cell hybrids, and the murine L-929 a subline cells were maintained in RPMI-
1640 culture medium (Flow Laboratories, Rockville, MD) supplemented with 10% FCS
(Flow Laboratories). All cell lines used were free of mycoplasma contamination on testing.
Antibodies. Antibodies B36.1 (anti-CD5 antigen on T cells, IgG2b) (27, 28); B73 .1
(anti-CD16 antigen on NK cells and polymorphonucleated granulocytes, IgGI) (27, 29);
B66.6 (anti-CD4 antigen on helper/inducer T cells, IgGI) (27); B116.1 (anti-CD8 antigen
on suppressor/cytotoxic T cells and a proportion of NK cells, IgGl) (27); B52.1 (anti-
CD14 antigen on monocytes, IgM) (18); B33.1 (anti-HLA-DR, nonpolymorphic determi-
nant, IgG2a) (27); B154.7 and B154.9 (non-crossreacting antibodies directed against two
distinct determinants of TNF and not reacting with LT, both IgGI) were produced and
characterized in our laboratory. Antibody OKT3 (anti-CD3 antigen on T cells, IgG2a)
(30) was produced from cells purchased from the American Type Culture Collection
(Rockville, MD). Either culture supernatant fluids or Ig antibodies purified from ascitic
fluids were used at predetermined optimal concentrations. Antibodies to human LT
(antibody LT-B, 5 x 102 neutralizing U/Icg IgG), to human TNF (antibody TNF-D, 2.7
x 104 neutralizing U/wg, TNF-E 6 x 10' neutralizing U/Ag), and a rabbit immune serum
anti-LT (2.9 x 10' neutralizing U/ml) were kindly provided by Dr. H . M. Shepard
(Genentech Inc., South San Francisco, CA). The goat F(ab')2 anti-mouse IgG used to
prepare the erythrocytes for indirect rosetting (see below) was produced in our laboratory,
absorbed on a column of human IgG coupled to Sepharose 4 B (Pharmacia Fine Chemicals,
Uppsala, Sweden) and further affinity purified on a mouse IgG-Sepharose 4 B column
(Pharmacia Fine Chemicals).
Human Peripheral Blood Leukocyte Populations. Peripheral blood was obtained by
venipuncture from adult healthy donors and was anticoagulated with heparin. Mononu-
clear cells were prepared by centrifugation on a Ficoll/Hypaque (F/H) density gradient
(1 .077 g/cms). Monocytes were prepared by adhering the mononuclear cells to plastic
flasks (3024, Falcon Labware, Oxnard, CA) for 45 min at 37°C in RPMI 1640 medium
with 10% FCS and recovered by scraping with a rubber policeman after careful removal
of nonadherent lymphocytes with several gentle washes with PBS. These cell preparations
were composed of >95% a-naphthyl-acetate-esterase (ANAE)-positive monocytes, and no
effort was made to eliminate a minor lymphocyte contamination. Nonadherent mononu-
clear cells, obtained after two cycles of adherence to plastic flasks for 45 min at 37°C,
were depleted of residual contaminating monocytes after sensitization with antibodies
B52 .1 and B33.1 (supernatant fluid 1 :4 final dilution, 20 jl per 106 cells), and indirect
rosetting with CrCls-treated sheep erythrocytes coated with goat F(ab')2 anti-mouse IgG;
rosetting (antibody-positive) and nonrosetting (antibody-negative) cells were separated
using F/H density gradient centrifugation, as previously described (27, 29, 31). The
nonrosetting cell populations (nonadherent HLA-DR-/B52 .1 - lymphocytes) were com-
posed mostly of T and NK cells, asjudged by surface phenotyping in indirect immunoflu-
orescence, and <1 in 10,000 ANAE+ cells could be detected on cytocentrifuge smears.
Several lymphocytes subsets (CD3-, CD3+, CD8-/CD 16-, CD4-/CD16-, CD 16-, CD 16')
were obtained from this lymphocyte population by indirect rosetting after sensitizationCUTURI ET AL.
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with the appropriate antibodies (OKT3, 1136.1, 1173 .1, 1166.6, and 11116 .1), as previously
described (29, 31).
Leukocyte Stimulation.
￿
Monocyte and lymphocyte preparations were cultured at 37'C
for the indicated periods of time in RPMI-1640 supplemented with 10% FCS (106 cells/ml)
in the presence of predetermined optimal concentrations of various inducers. Phorbol-
12,13-dibutyrate (PDBu) (Chemicals for Cancer Research, Inc., Eden Prairie, MN) was
used at 100 ng/ml final concentration; LPS from E. coli (serotype 0127:118, Sigma
Chemical Co., St. Louis, MO) at 10 wg/ml; A23187 calcium ionophore (free acid form,
Sigma Chemical Co.) at 0.5 t+g/ml; PHA (Wellcome S.A., Dartford, England) at 2%; Con
A (Pharmacia Fine Chemicals) at 0.5 ug/ml; rIL-2 (Takada Chemical Industry, Inc.,
Osaka, Japan, a generous gift of Dr. T. Taguchi of Osaka University, Japan) at 1,000
U/ml.
Recombinant Cytotoxins.
￿
Human rTNF (10' U/mg on L929 cells) and rLT (1 .2 X 108
U/mg) were kindly supplied by Dr. H . M . Shepard (Genentech, Inc.).
Assayfor LT Activity.
￿
Serial dilutions of cell-free supernatant fluids from the leukocyte
cultures induced as above were added to 3 X 10' mouse L-929 cells (a subline) per well
in 96-well flat-bottomed microtiter plates in the presence of 0.5 tag/ml actinomycin D
(Calbiochem Behring Corp., La Jolla, CA). Cytotoxicity was assessed by microscopic
examination after 48-h incubation at 37 °C. The concentration (U/ml) of LT for each
sample was defined as the reciprocal of the dilution that produced 50% cytotoxicity. To
ascertain that cytotoxicity was due to LT, the cell-free supernatant fluids from PBL
induced with different stimuli were separately incubated with the anti-LT or anti-TNF
monoclonal (5 wg/ml) or polyclonal antibodies (1 :1,000 dilution) for 6 h at 4° C before
being tested in the La cell cytotoxic assay.
TNFRadioimmunoassay (RIA).
￿
Anti-TNF antibody 11154.7, purified IgGI , was labeled
with Na "'I (1 mCi "'I per 20,ugprotein, sp act 13-17 mCi/tag; Amersham International,
Amersham, U .K.) using the chloramine T method. Antibody 11154.9 (5 g IgGI/ml in 0.1
M carbonate buffer, pH 9.5) was absorbed (50 Al/well, 48 h at VC) C) to 96-well vinyl plates
(Serocluster, Costar, Cambridge, MA). The plates were washed three times with cold PBS
containing 0.05% Tween 20 (Bio-Rad, Richmond, CA) (PBS-Tween), and 50 fal of test
samples were added to triplicate wells and incubated 18 h at 4°C. Plates were washed
three times with PBS-Tween, '21I-labeled antibody 11154.7 was added (0.1 wg/ml, 50
A1/well), and the plates were incubated for 18 h at VC. C. The plates were then washed six
times with cold PBS-Tween, dried, and bound radioactivity was measured in a Packard
Auto-Gamma 800 automated gamma counter (Packard Instrument Co., Downers Grove,
IL). The TNF concentrations in the test samples were determined on the basis of a
standard curve, constructed in each experiment using a rTNF standard (Fig. 1). The
sensitivity of this RIA is at least 0.01-0.02 ng/ml, corresponding to 0.1-0.2 U/ml in the
La cell assay. Two sources of natural TNF, obtained from HL-60 cells (induced by
phorbol ester, LPS and A23187, as described in Wang et al. [8]) and from human
lymphocytes (stimulated with PDBu and A23187) were detected in this RIA with a
sensitivity comparable to that observed with rTNF. Up to 10' U/ml of natural human
LT, purified for the supernatant fluid of PDBu-stimulated RPMI-8866 B cell line (18)
and up to 10' U/ml of rLT were not detected in the RIA (Fig. 1). rIFN-a, -,3, and -y, up
to 10 U/ml, were also not detected (not shown).
IFN-y . Radioimmunoassay.
￿
RIA for IFN-y was previously described (15). The sensitivity
of this RIA is 0 .2 U/ml of IFN-y, and no crossreaction with TNF, LT, or other species
of IFN is observed.
cDNA Probes.
￿
TNF and LT cDNA probes (kindly provided by Dr. H. M. Shepard,
Genentech, Inc.) were grown in E. coli DH5-competent cells. Both probes are Eco RI
restriction fragments from the coding region of human TNF and LT cDNA. IFN-'r
cDNA probe pSWIF (grown in HB101-competent cells) was kindly provided by Dr. Steven
C. Clark, Genetics Institute, Boston, MA. 82P-labeling of all probes was by nick translation
(32).
Northern Blot Hybridization.
￿
Total RNAs were prepared from uninduced and induced
cells using the phenol method. Briefly, cells were harvested by centrifugation, extensively1584
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1ogooo FIGURE 1 . RIA for TNF . Different
preparations of TNF and LT were ti-
trated for cytotoxic activity on La cells
and serial dilutions (containing the indi-
cated concentrations of cytotoxic units
on La cells) were tested in theTNF RIA,
as described . (0) rTNF (sp act, 10'
U/mg), (A) naturalTNF fromPDBu and
A23187-stimulated lymphocytes, (0)
natural TNF from phorbol diester,
A23187 and LPS-stimulated HL-60
cells, (") rLT (sp act 1 .2 X 108 U/mg),
([I) natural LT purified from superna-
tant fluid of PDBu-stimulated RPMI
8866 cells.
washed with cold PBS, and resuspended in hypotonic buffer (Tris-EDTA containing
0.65% [vol/vol] NP-40). The cell lysate was centrifuged, and the nuclei-free cytoplasmic
fraction was treated with 0.5% SDS before the phenol-chloroform extraction . Total
cytoplasmic RNA was precipitated for 18 h at -20° C with 2.5 volumes of 95% ethanol .
RNA samples were fractionated in a 1% agarose-formaldehyde gel (32) . Briefly, total
RNA was transferred to nitrocellulose paper and hybridized with nick-translated purified
DNA fragments bearing human TNF, LT, or IFN--y sequences . Filter-bound RNA was
hybridized with nick-translated probe in 50% formamide, 5 X SSC (I X = 0.15 M NaCl,
0.015 M Na3C6H504, pH 7.0), 1 X Denhardt's solution (0.02% polyvinylpyrrolidone,
0.02% BSA, 0.02% Ficoll 400), 20mM sodium phosphate buffer, pH 6.5, 10% dextran
sulfate, 100 ug/ml denatured salmon sperm DNA, 0.1% SDS at 42 ° C for 16 h . Filters
were prehybridized for 3-6 h at 42°C in 50% formamide, 5 X SSC, 5 X Denhardt's, 50
mM phosphate buffer, 250 gg/ml denatured salmon sperm DNA, and 0.1% SDS . After
hybridization the filters were washed at 50 °C with 0.5 X SSC, 0.2% SDS for 1 h and
autoradiographed using X-Omat AR film (Eastman Kodak, Rochester, NY) and an
intensifying screen (Dupont Co ., Wilmington, DE) .
Characterization ofTNF by Western Blot Analysis.
￿
Cell-free supernatants were obtained
from serum-free cultures of cells 18 h after induction . The supernatants were concentrated
fourfold and 5 pl aliquots (equivalent to the supernatant from 2 X 104 cells) was
electrophoresed in a 12.5% SDS-polyacrylamide gel under nonreducing conditions . West-
ern blotting onto nitrocellulose paper (Schleicher and Schuell, Keene, NH) was performed
according to Towbin (33) .
Blots were first blocked using 1% dry milk, 0.05% Tween-20 in 10mM Tris, 150 mM
NaCl, pH 7.5 . After incubation with 's "61-labeled anti-TNF antibodies B145 .7 and B145.9
(0.1 Ag/ml in Tris-NaCl, 0 .05% Tween 20) for 18 h at VC, C, blots were washed five times
with Tris-NaCl containing 0.25% NP-40, 0.25% Tween 20, dried and autoradiographed
for 92 h . rTNF, supernatants from unstimulated cells, and controls using 's5I-anti-IL-2
monoclonal antibodies were always run in parallel .
Results
Production ofTNFby Lymphocytes and Monocytes .
￿
Highly enriched preparations
of lymphocytes (nonadherent HLA-DR- peripheral blood mononuclear cells,
containing almost exclusivelyT and NK cells, and with <0.01% contamination
of ANAE+ monocytes) and of monocytes (adherent peripheral blood mononu-
clear cells containing >95% ANAE'' monocytes) were cultured for 6 h with
various inducers, and the concentration of TNF in the cell-free supernatant
fluids was measured by RIA . The RIA detects natural TNF and rTNF with
similar sensitivity, but does not detect LT or other lymphokines (Fig . 1) . Table
I gives results obtained using matched lymphocyte and monocyte preparationsTABLE I
TNFProduction by Human Peripheral Blood Lymphocytes
andMonocytes
Inducer
CUTURI ET AL .
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TNFproduced by :
Lymphocytes (nonadherent B52.1-/B33 .1- peripheral blood mononuclear
cells) and monocytes (plastic-adherent peripheral blood mononuclear cells)
from six donors were cultured (6 h, 37 ° C) in the presence of the various
inducers as described . Supernatant fluids were collected and tested for
TNFcontent using RIA .
from six donors . Both the phorbol diester PDBu and the calcium ionophore
A23187 stimulated TNF production from lymphocytes ; using both inducers
together, more than an additive effect was observed . The mitogens PHA and
Con A (6-h incubation) induced moderate levels of TNF from lymphocytes (<1
ng/mlon average), and PHA-inducedTNF production was potentiated by PDBu .
rIL-2 or LPS induced only minimal levels ofTNF production from lymphocytes .
Monocytes but not lymphocytes constitutively produced low levels of TNF,
possibly due to a low endotoxin contamination (<2 ng/ml by the Limulus assay)
of the culture medium . Production ofTNF in monocyte cultures was maximally
induced by LPS and by PDBu . PDBu, however, did not synergize with LPS,
A23187, or PHA in inducing TNF production by monocytes .
The kinetics of TNF production in cultures of lymphocytes stimulated with
PDBu, A23187, a combination of PDBu and A23187, or PHA was analyzed
with lymphocytes from four donors and compared with the production of IFN-
-y and of cytotoxic activity on L929a cells (Fig. 2) . Significant TNF titers were
induced by PDBu and by PDBu and A23187 within 6 h, and those values were
maximum at 24 h of incubation (Fig . 2A) . No significant TNF production was
observed in supernatants from 6-h PHA-induced lymphocytes, but levels ofTNF
comparable to those observed upon PDBu-induction were detected after 24-h or
longer induction . The production of IFN-'Y in the same cell-free supernatants
paralleled that observed for TNF, although the kinetics of induction with PDBu
orPHA was slower and no significant production was measured at 6 h (Fig. 2B) .
High levels of both IFN--y and TNF were detected in the supernatant fluids from
lymphocytes stimulated for 6 h with PDBu and A23187 .
The cytotoxic activity of the supernatants was tested on L929a cells (Fig . 2 C) .
Cytotoxic activity in supernatants from PHA-induced lymphocytes, especially at
incubation times longer than 24 h, was higher than that detected in supernatants
Lymphocytes
ng/ml
Monocytes
None <0.02 0.20 ± 0.20
PDBu 0.80 ± 0.80 3.50 t 3.40
A23187 0.40 ± 0.40 0.40 t 0.50
PDBu + A23187 20.28 ± 15.91 2.80 ± 1 .90
PHA 0.60 ± 0.40 0.30 t 0.40
PDBu + PHA 4.20 ± 1 .30 3.70 f 2.40
LPS 0.20 ± 0.20 9.80 ± 13.60
PDBu + LPS 1 .00 ± 0.90 10.20 t 5.40
ConA 0.70 ± 0.80 0.30 t 0.40
IL-2 0.10 t 0.20 0.40 ± 0.501586
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FIGURE 2.
￿
Production ofcytotoxins andIFN-7by lymphocytes. Lymphocytes (nonadherent,
B52.1 -/B33.1 - peripheral blood mononuclear cells) were cultured in the presence of the
different inducers, cell-free supernatant fluids were collected at the indicated time, dialyzed
extensively and assayed for TNF (A) and IFN-7 (B) by RIA and for cytotoxins (C) in a La
cytotoxic assay. Cells were cultured in RPMI 10% FCS with no inducer(O) or in the presence
of (0) PDBu, (EI) A23187, (/) PDBu + A23187, (A) PHA. Experimental points are mean ±
SE of four experiments.
from PDBu- or PDBu and A23187-induced cells, suggesting that another cyto-
toxin(s) active on L929a cells was produced in PHA-stimulated cultures, in
addition to the TNF measured by RIA (Fig. 2A) . Therefore, the cytotoxic
activity on L929a cells in the supernatant fluids obtained at 24 and 72 h from
lymphocyte preparations cultured in the presence of various inducers was further
characterized in neutralization experiments using inactivating antibodies specific
for TNF or LT (Table II). In all cases, the greatest inhibition was observed when
both anti-TNF and anti-LT antibodies were added to the supernatant fluids,
suggesting the presence of both LT and TNF in the supernatant fluids. The
remaining cytotoxic activity observed when both anti-TNF and anti-LT antibod-
ies were used could be due to a cytotoxin different from both TNF and LT or,
more likely, to incomplete activation of TNF and LT by the antibodies. In most
preparations from cells stimulated with PDBu and A23187 for 24 h (Table II)
or less (not shown) an almost complete inhibition was, however, observed with
anti-TNF antibodies alone, suggesting that TNF is the predominant source of
cytotoxin produced during early times of culture. Inhibition ofcytotoxic activity
was almost never observed using an inactivating monoclonal antibody against
I FN-7 (antibody B133.3).
TNF Production by Lymphocyte Subpopulations.
￿
TNF production was evaluated
in the supernatant fluids from lymphocyte preparations enriched for specific
lymphocyte subpopulations and stimulated with PDBu and A23187 for 6 h
(Table III). T cells (>95% pure), obtained by either negative or positive selection
using anti-CD16 antibody B73.1 or anti-CD3 antibody OKT3, respectively,
produced the same or higher TNF levels than the total HLA-DR- lymphocytes.
The T cells positively selected with the anti-CD3 antibody produced significant
TNF levels even in the absence of PDBu and A23187, probably due to the
stimulatory effect of the antibody used for the separation. Both T cell prepara-CUTURI ET AL. 1587
TABLE II
Cytotoxic Activity on La Cells Mediated by Supernatant Fluidsfrom Stimulated Lymphocytes:
Inactivation by Anti-LT and Anti-TNF Antibodies
Cytotoxic activity on La cells in supernatants
treated with:
Lymphocytes (nonadherent B52.1 -, B33.1 - peripheral blood mononuclear cells) from three donors
were cultured in the presence ofthe various inducers as described . Supernatant fluids were collected
at the indicated time and tested for cytotoxicity on La cells after 6-h preincubation at 4°C with the
indicated antibodies. In Exp. A and B, monoclonal antibody TNF-E and a rabbit antiserum anti-LT
were used; in Exp. C monoclonal antibodies TNF-D and LT-B were used.
TABLE III
Production of TNF by Lymphocyte Subpopulations
The indicated lymphocyte subsets from four donors were obtained by indirect rosetting and cultured
in the presence or absence of PDBu and A23187 as described. Cell-free supernatant fluids (n = 4)
were collected after 6-h culture and tested for TNF content using RIA .
Exp. Inducer Time
h
Nothing Anti-
-1-NF
Anti-
LT
U/ml
Anti-
TNF +
anti-LT
Anti-
IF,N-7
A PDBu + A23187 24 4 0 4 0 4
PHA 24 8 8 4 0 8
PDBu + A23187 72 64 32 4 0 64
PHA 72 128 32 32 4 128
PDBu + PHA 72 16 8 8 4 32
B PDBu + A23187 24 8 4 4 0 8
PHA 24 32 8 8 0 32
PDBu + PHA 24 8 4 4 0 8
PDBu + A23187 72 64 32 8 0 64
PHA 72 256 64 64 0 128
PDBu + PHA 72 32 16 16 4 32
C PDBu + A23187 24 8 2 8 0 8
PHA 24 16 8 8 8 16
PDBu + PHA 24 16 8 8 4 16
PDBu + A23187 72 16 4 8 0 16
PHA 72 64 64 32 16 64
PDBu + PHA 72 128 32 64 16 128
PBL subset
TNF produced in PBL
Nothing
ng/ml
induced by:
PDBu + A23187
HLA-DR- 0.02 ± 0.02 7 .52 ± 5 .80
HLA-DR-, CDI6- <0.01 7 .62 ± 6.47
HLA-DR-, CD3' 3.30 ± 0.30 19 .00 ± 4.00
HLA-DR-, CD8-, CD16- 0.10 ± 0.17 10 .15 ± 4.65
HLA-DR-, CD4-, CID 16- 0.02 ± 0.03 3.70 ± 2.21
HLA-DR-, CD3- 0.01 ± 0.02 1 .60 ± 1 .45
HLA-DR-, CD16+ <0.01 3.00 ± 1 .401588
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TABLE IN'
TNF Production by Lymphocytes and NK Cell-enriched Preparations
Inducer
TNF produced by:
Lymphocytes
￿
NK cells
Lymphocytes (nonadherent, 1352.1-, 1333.1 - peripheral blood mononu-
clear cells) and NK cell-enriched preparations obtained after T cell
depletion using antibodies 1336.1 and OKT3 were cultured in the presence
of the various inducers as described. Supernatant fluids (n = 3) were
collected at 24 h and tested for TNF content using RIA.
tions enriched (>90% pure) for CD4+ (helper/Inducer T cells) and for (:D8+
cells (suppressor/cytotoxic T cells) by negative selection produced TNF upon
stimulation with PDBu and A23187, although, on average, CD4+-enriched cells
produced approximately threefold higher TNF levels than CD8+-enriched cells
(Table III) . Lymphocyte preparations enriched (>90% pure) for NK cells by
negative (CD3- cells) or positive (CD16+ cells) selection consistently produced
TNF levels lower than total lymphocytes or T cell-enriched preparations . The
ability of lymphocyte preparations highly enriched in NK cells [nonadherent
HLA-DR-/CD3-/CD5- lymphocytes, containing >95% CD16 (1373 .1)+ NK cells]
to produce TNF in response to various stimuli was compared to that of nonad-
herent HLA-DR- lymphocytes (Table IV). NK cells produced TNF only in
response to PDBu plus A23187 and to PDBu plus PHA, although, on average,
at levels 7- and 50-fold lower than lymphocytes, respectively. Unlike total
lymphocytes, NK cells failed to produce TNF in response to PDBu or to PHA
used alone . NK cells induced with LPS or with LPS and PDBu also did not
produce TNF.
Transcription of TNF and LT Genes in Lymphocytes.
￿
The presence of TNF,
LT, and IFN-y mRNA was analyzed by Northern blotting in lymphocytes
stimulated with PDBu and A23187, PHA, or LPS (Fig. 3). No mRNA for any
of the lymphokines tested was detected in cultured unstimulated lymphocytes or
in lymphocytes cultured in the presence of LPS . The TNF and IFN-y mRNA,
and, to a lesser extent, the LT mRNA were detected in PBL upon 6-h induction
with PDBu and A23187. LT and IFN-y mRNA and, at a much lower level, TNF
mRNA were detected at 24 h, but not at 6 h after PHA-induction. Similar levels
of mRNA were present in all preparations as monitored by hybridization to a
human 0-actin probe (not shown) . The levels of mRNA detected in Fig. 3
correlate well with the amounts of TNF and IFN-y proteins detected by RIA
and the LT cytotoxic activity in the La assay.
Characterization of the TNF Produced by Lymphocytes.
￿
The TNF, as identified
None
PDBu
A23187
0 .03 ±
1 .20 ±
<0.2
ng/ml
0.04
0.90
0.03 ± 0.04
<0.02
<0.02
PDBu + A23187 13 .16 ± 4.73 1 .80 ± 2.26
PHA 3 .03 ± 2.67 <0.02
PDBu + PHA 21 .33 ± 8.73 0.43 ± 1 .69
LPS 0.55 ± 0.60 <0.02
PDBu + LPS 3 .66 ± 2.62 0.06 ± 0.09CUTURI ET AL .
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FIGURF, 3. Induction of TNF (A), IFN-y (B), and LT (C) mRNA in activated human
lymphocytes . Total cytoplasm RNA was extracted from lymphocytes (nonadherent
B33.1 -/1352 .1 - mononuclear peripheral blood cells) cultured in the presence of various
inducers and electrophoresed on a 1 % agarose-formaldehyde gel (20 Wg per lane) . After
transfer to nitrocellulose, RNA was hybridized to the indicated cDNA probes . Lane 1,
lymphocytes cultured for 6 h in control medium in the absence of any inducer ; lane 2,
lymphocytes cultured for 6 h with PDBu and A23187 ; lanes 3 and 4, lymphocytes cultured
for 6 h and, for 24 h, respectively, in the presence of PHA; lane 5, lymphocytes cultured for
6 h in thepresence of LPS.
FIGURE 4.
￿
Western blotting of TNF-containing super-
natants using "51-labeled monoclonal anti-TNF antibod-
ies13145.5 and 13145 .7 . Lanes 1and 6, rTNF, 10 ng ; lane
2, cell-free supernatant fluid from serum-free PDBu and
A23187-stimulated lymphocytes ; lane 3, "C-labeled
markers (X 1V) ; lane 4, cell-free supernatant fluid from
PDBu, A23187, and LPS-stimulated HL-60 cells ; lane 5,
cell-free supernatant fluid from LPS-stimulated mono-
cytes .
by RIA, produced by lymphocytes induced with PDBu and A23187, has physi-
cochemical characteristics identical to the TNF produced by monocytes or HL-
60 cells, and to rTNF, when analyzed by gel filtration or by anion-exchange
chromatography (data not shown) . The same comparison by Western blotting
using "'I-labeled anti-TNF antibodies reproducibly revealed a band with iden-
tical migration, and with Mr of 17,000 in supernatant fluids from stimulated
lymphocytes, monocytes, or HL-60 cells and in a preparation ofrTNF (Fig . 4) .
When supernatant fluids from unstimulated lymphocytes were analyzed by
Western blotting, no polypeptides reacting with anti-TNF antibodies were de-
tected (not shown) .1590
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Discussion
The results presented in this report show that lymphocytes areable to produce
TNF. This conclusion is based on analysis, in highly purified lymphocyte prepa-
rations, of both TNF secretion, using a sensitive and highly specific RIA, and
transcription of the TNF gene. The RIA for TNF is at least five times more
sensitive than the biological assay and, unlike the latter, does not crossreact with
LT or othercytotoxins. The RIA simultaneously used two monoclonal antibodies
specific for two separate antigenic determinants on the TNF molecule; thus,
false positive results due to a crossreacting specificity ofonly one oftheantibodies
is unlikely. Up to 10' U ofrLT or 103 U of B cell line-derived natural LT gave
no signal in the RIA, whereas <1 U ofrTNF or natural TNF was easily detected.
The possibility that the cells producing TNF in our lymphocyte preparations
were contaminating monocytes was excluded both by the careful depletion
procedures and by the differential response to the stimuli that induce production
of TNF from lymphocyte and monocyte preparations. LPS, a potent inducer of
TNF production by monocytes, did not induce any significant production of
TNF from lymphocytes, confirming that contaminant monocytes were not the
producers of TNF in our lymphocyte cultures. Phorbol diesters induced TNF
production in both lymphocytes and monocytes, but the synergistic induction of
TNF using phorbol diester and calcium ionophore in combination was observed
only with lymphocyte preparations. Mitogenic lectins, alone or synergistically
with phorbol diesters, were efficient inducers of TNF from lymphocytes, but not
from monocytes. These results suggest that both protein kinase C activation and
increase in intracellular calcium may play a role in the production of TNF by
lymphocytes. Similarobservations have been reported for induction ofthe human
IFN-y and IL-2 genes (35).
Analysis by Northern blotting showed that accumulation of TNF, LT, and
IFN-y mRNA was demonstrable in lymphocyte preparations stimulated with
phorbol diester and calcium ionophore, or with PHA. Interestingly, when the
ability of phorbol diester and calcium ionophore to induce TNF, LT, and IFN-
y was compared with that ofthe mitogen PHA, the first combination ofinducers
maximally induced accumulation of mRNA for TNF and IFN-y. In contrast,
PHA, although with slower kinetics than PDBu and A23187, induced accumu-
lation preferentially of LT mRNA, although TNF and IFN-y mRNA were also
detected. Thus, accumulation of the IFN-y and TNF messages responds to
stimuli in a manner discordant with the LT gene, suggesting a different regula-
tory mechanism. These results only document steady-state accumulation of
mRNA, and do not allow us to distinguish whether this results from increased
transcription or decreased mRNA degradation. We consider the former possi-
bility more likely, because no message can be detected in unstimulated lympho-
cytes and because no spontaneous production of any of the three lymphokines is
observed in short-term cultures of fresh lymphocytes. The independent regula-
tion of the TNF and LT genes was confirmed by analyzing the kinetics of
synthesis of the two cytotoxins. These semiquantitative data, based on inactiva-
tion of biological activity on L929a cells using specific antibodies, show that
phorbol diesters and calcium ionophore at early times induce mostly or exclu-
sively TNF, whereas LT, which is the major cytotoxin species induced by PHA,CUTURI ET AL .
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is produced at later times in culture . The temporal regulation of production of
IFN-y by lymphocytes closely paralleled the production ofTNF, consistent with
the results obtained by analysis of mRNA expression . TNF and LT have almost
identical biological activity and are encoded by two closely linked genes in the
major histocompatibility complex region (36) . Although they share almost 50%
nucleotide homology in the protein coding region (7), the two genes differ in
their flanking regions (7) . The close linkage betweenTNF and LT genes suggests
that, rather than differences in chromatin organization, promoter-specific factors
and upstream regulatory sequences might be responsible for the differential
regulation of expression of these two genes .
To completely eliminate monocytes from our lymphocyte preparations, we
used treatments (i .e . depletion of HLA-DR' cells) that also remove B cells, and
therefore, the preparations used contained almost exclusivelyT and NK cells . T
cells, both CD4+ enriched and CD8+ enriched, were the most efficient producers
of TNF, especially upon mitogen stimulation . The observation that most of the
TNF production is associated with T cell preparations, obtained using positive
selection, excludes the possibility that contaminant cell types such as basophils,
previously reported to produce TNF (34), account for most of the TNF produc-
tion .
Our previous data (14) clearly indicate that NK cells are needed for TNF
production in NK cell/target cell cultures . The demonstration of production of
TNF in coculture of NK cells with cell lines (14, 20) or with normal bone marrow
cells (14), though suggestive of a role for TNF in NK cell functions such as
suppression of hematopoietic colony inhibition, remains difficult to interpret
because of the possibility that the cells used as stimulators act as accessory cells
or even directly participate inTNF production . The inducers used in the present
study are probably not optimal for NK cell stimulation . Lectins such as PHA and
Con A are not mitogenic for and do not activate NK cells (37) . Phorbol diesters
and calcium ionophore, although affecting NK cell functions (38), are much
better inducers of IFN-y production in T cells than in NK cells (38), although
the latter cell type is preferentially induced to produce IFN-'Y when stimulated
by IL-2 (39) . However, the present data confirm the ability of NK cells to
produce TNF, although at a lower level than T cells . The possibility that T cells
contaminating the enriched NK cell preparations are responsible for TNF
production is unlikely, not only because careful cell purification procedures were
used, but also because the mitogen PHA, a powerful inducer of TNF in T cells,
was inactive on NK cell-enriched preparations . We have also obtained prelimi-
nary results demonstrating transcription of the TNF gene in stimulated prepa-
rations of pure NK cells (our unpublished observation) . The complete under-
standing of the regulation of TNF production by NK cells and of the role of
TNF in NK cell functions awaits a better analysis of the effect ofNK cell-specific
stimuli and of the role of accessory cells in cytokine production by different cell
types .
Summary
We present evidence that human peripheral blood lymphocytes, free of con-
taminating monocytes, rapidly produce high levels of tumor necrosis factor1592
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(TNF) when stimulated with phorbol diester and calcium ionophore, and lower
but significant levels of TNF when stimulated with mitogens . These two types
of inducers act preferentially on T cells, both CD4+ andCD8+ . NK cells produce
TNF only when stimulated with phorbol diester and calcium ionophore, and
they do so at a much lower level than T cells . The procedures used in the
purification of lymphocytes and the differential ability to respond to various
inducers allow us to exclude that monocytes or basophils contaminating the
lymphocyte preparation participate in the production of TNF . In particular,
ITS, a potent inducer of TNF production from monocytes, is unable to induce
significant levels of TNF in the lymphocyte preparations . The TNF produced
by lymphocytes has antigenic, physicochemical, and biochemical characteristics
identical to those of the TNF produced by myeloid cell lines or monocytes upon
stimulation with LPS . LT is also produced by lymphocyte preparations . Produc-
tion of TNF and LT proteins in response to the different inducers is paralleled
by accumulation of cytoplasmic TNF and LT inRNA . Both at mRNA and at
protein levels, stimulation of T lymphocytes with phorbol diester and calcium
ionophore preferentially induces TNF, whereas mitogen stimulation preferen-
tially induces LT . Our data suggest that the TNF and LT genes, two closely
linked genes encoding two partially homologous proteins with almost identical
biological functions, are independently regulated in lymphocytes .
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